Company profile
T-Cypher Bio
Pioneering next generation immune engagers
- Industry
- Biotechnology Research
- Employees
- 41
- Headquarters
- Oxford
- Founded
- 2021
- Office locations
- 1
T-Cypher Bio company summary
T-Cypher Bio is a company in the Biotechnology Research industry, headquartered in Oxford, founded in 2021. On LinkedIn the company has around 41 employees.
What technology does T-Cypher Bio use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About T-Cypher Bio
T-Cypher was founded as a deep tech company with the mission of tackling one of the greatest unsolved challenges in human biology: How do we identify the specificities of the T cell populations that drive immune system failure, and use this knowledge to treat disease? Solving this problem would allow us to elucidate the origins of immune-mediated disease in humans, be transformative for drug development and directly lead to the design of next-generation therapeutics. To succeed in this mission, T-Cypher scientists designed, built and populated a unique data architecture that incorporates massive, diverse datasets relating to T cell immunology and cellular communication. This platform combines proprietary computational and wet-lab systems and today hosts data of the scale and quality required to understand T cell surveillance. We call the platform T-C Alpha. T-Cα effectively maps both sides of the T cell immune synapse. It maps the signature peptides our body uses in the communication of health and disease, and in parallel maps the reactivity of T cell repertoires. It does this at the scale, diversity and sensitivity of the human immune system. Today, T-Cα is a fully integrated discovery platform and machine learning engine profiling the human disease target space and its associated T cell reactivity. We use it to discover and develop next generation therapeutics for immune-mediated diseases.
Where is T-Cypher Bio located?
T-Cypher Bio lists 1 location.
Compare companies similar to T-Cypher Bio
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
T-Cypher Bio tcypherbio.com | Biotechnology Research | 41 | 2021 | Oxford |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about T-Cypher Bio
What does T-Cypher Bio do?
T-Cypher was founded as a deep tech company with the mission of tackling one of the greatest unsolved challenges in human biology: How do we identify the specificities of the T cell populations that drive immune system failure, and use this knowledge to treat disease? Solving this problem would allow us to elucidate the origins of immune-mediated disease in humans, be transformative for drug development and directly lead to the design of next-generation therapeutics. To succeed in this mission, T-Cypher scientists designed, built and populated a unique data architecture that incorporates massive, diverse datasets relating to T cell immunology and cellular communication. This platform combines proprietary computational and wet-lab systems and today hosts data of the scale and quality required to understand T cell surveillance. We call the platform T-C Alpha. T-Cα effectively maps both sides of the T cell immune synapse. It maps the signature peptides our body uses in the communication of health and disease, and in parallel maps the reactivity of T cell repertoires. It does this at the scale, diversity and sensitivity of the human immune system. Today, T-Cα is a fully integrated discovery platform and machine learning engine profiling the human disease target space and its associated T cell reactivity. We use it to discover and develop next generation therapeutics for immune-mediated diseases.
How many employees does T-Cypher Bio have?
T-Cypher Bio has around 41 employees on LinkedIn.
Where is T-Cypher Bio headquartered?
T-Cypher Bio is headquartered in Oxford.
When was T-Cypher Bio founded?
T-Cypher Bio was founded in 2021.
Build a lead list from companies like T-Cypher Bio
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.